Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Concussion | 93 | 2024 | 1320 | 13.990 |
Why?
|
Post-Concussion Syndrome | 21 | 2023 | 219 | 4.800 |
Why?
|
Athletic Injuries | 41 | 2023 | 1154 | 4.560 |
Why?
|
Football | 17 | 2024 | 460 | 2.730 |
Why?
|
Firearms | 10 | 2024 | 598 | 2.700 |
Why?
|
Craniocerebral Trauma | 8 | 2023 | 482 | 2.440 |
Why?
|
Emergency Service, Hospital | 39 | 2022 | 7659 | 2.260 |
Why?
|
Brain Injuries | 14 | 2022 | 2025 | 2.090 |
Why?
|
Suicide | 7 | 2024 | 1477 | 2.080 |
Why?
|
Accidents, Traffic | 5 | 2018 | 819 | 1.730 |
Why?
|
Wounds, Gunshot | 6 | 2024 | 563 | 1.510 |
Why?
|
Homicide | 6 | 2022 | 287 | 1.460 |
Why?
|
Maze Learning | 10 | 2023 | 478 | 1.320 |
Why?
|
Athletes | 22 | 2023 | 1093 | 1.300 |
Why?
|
Spinal Injuries | 3 | 2019 | 301 | 1.260 |
Why?
|
Memantine | 2 | 2019 | 100 | 1.230 |
Why?
|
Behavior, Animal | 5 | 2023 | 1881 | 1.180 |
Why?
|
Recovery of Function | 10 | 2021 | 2925 | 1.070 |
Why?
|
Sports | 8 | 2023 | 688 | 1.050 |
Why?
|
Adolescent | 92 | 2024 | 85781 | 1.000 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2019 | 895 | 0.980 |
Why?
|
Child Restraint Systems | 2 | 2015 | 20 | 0.970 |
Why?
|
Child | 80 | 2024 | 77709 | 0.940 |
Why?
|
Optic Nerve Injuries | 2 | 2022 | 150 | 0.940 |
Why?
|
Vision Disorders | 2 | 2021 | 1058 | 0.900 |
Why?
|
Wounds and Injuries | 5 | 2023 | 2400 | 0.880 |
Why?
|
Pediatrics | 9 | 2022 | 3475 | 0.760 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2013 | 311 | 0.750 |
Why?
|
Soccer | 5 | 2022 | 133 | 0.740 |
Why?
|
Wounds, Nonpenetrating | 5 | 2019 | 794 | 0.740 |
Why?
|
Cervical Vertebrae | 4 | 2015 | 975 | 0.740 |
Why?
|
Jugular Veins | 2 | 2020 | 204 | 0.700 |
Why?
|
Amyloid Precursor Protein Secretases | 3 | 2021 | 584 | 0.680 |
Why?
|
Child, Preschool | 40 | 2024 | 41006 | 0.660 |
Why?
|
Head Injuries, Closed | 3 | 2022 | 136 | 0.650 |
Why?
|
Humans | 170 | 2024 | 744343 | 0.650 |
Why?
|
Brain | 24 | 2024 | 26385 | 0.650 |
Why?
|
Male | 118 | 2024 | 350118 | 0.640 |
Why?
|
Physicians | 5 | 2020 | 4567 | 0.620 |
Why?
|
Hospital Charges | 2 | 2016 | 362 | 0.610 |
Why?
|
Scalp | 1 | 2020 | 380 | 0.600 |
Why?
|
Trauma Centers | 4 | 2022 | 890 | 0.600 |
Why?
|
Housing, Animal | 1 | 2017 | 48 | 0.600 |
Why?
|
Cross-Sectional Studies | 34 | 2023 | 25043 | 0.590 |
Why?
|
Infant | 34 | 2023 | 35136 | 0.590 |
Why?
|
Melatonin | 1 | 2023 | 721 | 0.590 |
Why?
|
Random Allocation | 6 | 2017 | 2429 | 0.570 |
Why?
|
Trauma Severity Indices | 5 | 2021 | 481 | 0.560 |
Why?
|
Narcotics | 1 | 2018 | 343 | 0.550 |
Why?
|
Skull Fractures | 3 | 2020 | 195 | 0.550 |
Why?
|
United States | 41 | 2024 | 69872 | 0.540 |
Why?
|
Oligodendroglia | 1 | 2019 | 517 | 0.540 |
Why?
|
Hospitals, Pediatric | 5 | 2021 | 1775 | 0.530 |
Why?
|
Seat Belts | 1 | 2015 | 57 | 0.530 |
Why?
|
Epidemics | 1 | 2021 | 523 | 0.530 |
Why?
|
Patient Admission | 2 | 2021 | 1380 | 0.520 |
Why?
|
Hematoma | 1 | 2020 | 758 | 0.520 |
Why?
|
Adolescent Behavior | 1 | 2024 | 1151 | 0.520 |
Why?
|
Behavior | 1 | 2018 | 561 | 0.510 |
Why?
|
Exanthema | 1 | 2020 | 501 | 0.510 |
Why?
|
Public Policy | 1 | 2019 | 572 | 0.500 |
Why?
|
Automobiles | 1 | 2015 | 116 | 0.500 |
Why?
|
Female | 104 | 2024 | 380194 | 0.500 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2017 | 449 | 0.490 |
Why?
|
Tomography, X-Ray Computed | 13 | 2021 | 20129 | 0.490 |
Why?
|
Head | 1 | 2020 | 880 | 0.490 |
Why?
|
Medicine | 2 | 2020 | 946 | 0.480 |
Why?
|
Neck Pain | 1 | 2015 | 180 | 0.480 |
Why?
|
Gliosis | 1 | 2014 | 245 | 0.460 |
Why?
|
Mental Disorders | 3 | 2019 | 6600 | 0.450 |
Why?
|
Population Surveillance | 1 | 2023 | 2616 | 0.440 |
Why?
|
Head Protective Devices | 1 | 2013 | 114 | 0.410 |
Why?
|
Mice, Inbred C57BL | 13 | 2022 | 21827 | 0.410 |
Why?
|
Bicycling | 1 | 2013 | 176 | 0.400 |
Why?
|
Insurance, Health | 3 | 2013 | 2494 | 0.400 |
Why?
|
Triage | 1 | 2018 | 976 | 0.390 |
Why?
|
Diagnostic Imaging | 2 | 2015 | 3507 | 0.390 |
Why?
|
Hockey | 3 | 2022 | 90 | 0.380 |
Why?
|
Retrospective Studies | 32 | 2023 | 77449 | 0.380 |
Why?
|
Cognition | 10 | 2023 | 6770 | 0.380 |
Why?
|
Insurance Coverage | 2 | 2012 | 1901 | 0.380 |
Why?
|
Young Adult | 33 | 2023 | 56430 | 0.370 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 941 | 0.370 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2012 | 214 | 0.370 |
Why?
|
Progesterone | 1 | 2014 | 776 | 0.360 |
Why?
|
Healthcare Disparities | 3 | 2023 | 3158 | 0.350 |
Why?
|
Cost of Illness | 2 | 2016 | 1859 | 0.350 |
Why?
|
Unconsciousness | 3 | 2016 | 263 | 0.330 |
Why?
|
Infant, Newborn | 15 | 2022 | 25625 | 0.330 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2013 | 1121 | 0.320 |
Why?
|
Disease Models, Animal | 14 | 2023 | 18029 | 0.310 |
Why?
|
Neuropsychological Tests | 11 | 2024 | 6993 | 0.310 |
Why?
|
Status Asthmaticus | 1 | 2007 | 22 | 0.300 |
Why?
|
Amyloid beta-Peptides | 4 | 2013 | 3587 | 0.300 |
Why?
|
Animals | 30 | 2024 | 168757 | 0.290 |
Why?
|
Sports Medicine | 3 | 2021 | 225 | 0.290 |
Why?
|
Sampling Studies | 2 | 2021 | 623 | 0.280 |
Why?
|
Carcinoma | 1 | 2018 | 2375 | 0.280 |
Why?
|
Ambulatory Care | 2 | 2018 | 2708 | 0.280 |
Why?
|
Patient Care | 1 | 2012 | 640 | 0.280 |
Why?
|
MicroRNAs | 2 | 2024 | 3752 | 0.280 |
Why?
|
Child Health Services | 1 | 2012 | 667 | 0.280 |
Why?
|
Postural Balance | 3 | 2020 | 620 | 0.280 |
Why?
|
Apolipoprotein E4 | 1 | 2010 | 668 | 0.270 |
Why?
|
Hospitalization | 8 | 2022 | 10262 | 0.270 |
Why?
|
Risk Factors | 18 | 2024 | 72290 | 0.270 |
Why?
|
Gait | 3 | 2022 | 793 | 0.270 |
Why?
|
Pain | 2 | 2022 | 4986 | 0.260 |
Why?
|
Software | 1 | 2020 | 4443 | 0.260 |
Why?
|
Outpatients | 1 | 2013 | 1486 | 0.260 |
Why?
|
Rhabdomyolysis | 1 | 2006 | 150 | 0.260 |
Why?
|
Adult | 34 | 2024 | 214055 | 0.250 |
Why?
|
Prospective Studies | 23 | 2023 | 53288 | 0.250 |
Why?
|
Mice | 17 | 2024 | 81183 | 0.250 |
Why?
|
Health Care Surveys | 6 | 2019 | 2453 | 0.250 |
Why?
|
Prognosis | 10 | 2024 | 29063 | 0.250 |
Why?
|
Muscle Stretching Exercises | 2 | 2021 | 33 | 0.240 |
Why?
|
Age Factors | 11 | 2019 | 18370 | 0.240 |
Why?
|
Hippocampus | 3 | 2018 | 3675 | 0.240 |
Why?
|
Geographic Information Systems | 2 | 2023 | 281 | 0.240 |
Why?
|
Exercise Therapy | 3 | 2021 | 906 | 0.240 |
Why?
|
Attitude of Health Personnel | 2 | 2017 | 3843 | 0.240 |
Why?
|
Sex Characteristics | 1 | 2014 | 2585 | 0.240 |
Why?
|
Mental Health | 1 | 2018 | 3019 | 0.240 |
Why?
|
Axons | 6 | 2019 | 1684 | 0.240 |
Why?
|
Health Policy | 1 | 2016 | 2661 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3674 | 0.230 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8949 | 0.230 |
Why?
|
Multivariate Analysis | 6 | 2015 | 12245 | 0.230 |
Why?
|
Students | 5 | 2020 | 1654 | 0.230 |
Why?
|
Cognition Disorders | 5 | 2023 | 4043 | 0.220 |
Why?
|
Glial Fibrillary Acidic Protein | 4 | 2022 | 528 | 0.220 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4253 | 0.210 |
Why?
|
Microglia | 3 | 2017 | 1266 | 0.210 |
Why?
|
Self Report | 6 | 2022 | 3558 | 0.210 |
Why?
|
Memory | 3 | 2021 | 2174 | 0.210 |
Why?
|
Quality of Life | 6 | 2023 | 12804 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Swine | 3 | 2024 | 5917 | 0.210 |
Why?
|
Motor Activity | 4 | 2017 | 2714 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Poisson Distribution | 2 | 2013 | 513 | 0.200 |
Why?
|
tau Proteins | 3 | 2017 | 1868 | 0.200 |
Why?
|
Cranial Nerve Diseases | 1 | 2022 | 112 | 0.200 |
Why?
|
Cerebral Cortex | 3 | 2017 | 5708 | 0.200 |
Why?
|
Point-of-Care Systems | 3 | 2022 | 1177 | 0.200 |
Why?
|
Regression Analysis | 6 | 2023 | 6459 | 0.200 |
Why?
|
Exercise | 7 | 2023 | 5615 | 0.200 |
Why?
|
Reproductive Rights | 1 | 2021 | 35 | 0.200 |
Why?
|
Suicidal Ideation | 2 | 2024 | 1248 | 0.190 |
Why?
|
Patient Discharge | 4 | 2020 | 3313 | 0.190 |
Why?
|
Lyme Disease | 2 | 2022 | 621 | 0.190 |
Why?
|
Time Factors | 12 | 2021 | 40075 | 0.190 |
Why?
|
Guillain-Barre Syndrome | 1 | 2022 | 120 | 0.190 |
Why?
|
Length of Stay | 4 | 2021 | 6309 | 0.190 |
Why?
|
Intracranial Hemorrhage, Traumatic | 1 | 2021 | 54 | 0.190 |
Why?
|
Mental Healing | 1 | 2020 | 29 | 0.190 |
Why?
|
Health Status Disparities | 1 | 2012 | 1797 | 0.190 |
Why?
|
Meningitis | 1 | 2022 | 216 | 0.180 |
Why?
|
Ophthalmoscopes | 1 | 2020 | 23 | 0.180 |
Why?
|
Borrelia burgdorferi | 1 | 2022 | 180 | 0.180 |
Why?
|
Infant Mortality | 2 | 2023 | 754 | 0.180 |
Why?
|
Diuretics, Osmotic | 1 | 2019 | 37 | 0.180 |
Why?
|
Conditioning, Operant | 1 | 2021 | 313 | 0.180 |
Why?
|
Decision Making | 1 | 2014 | 3887 | 0.180 |
Why?
|
Ondansetron | 1 | 2020 | 90 | 0.180 |
Why?
|
Electroretinography | 1 | 2021 | 509 | 0.180 |
Why?
|
Emergency Medicine | 3 | 2020 | 1207 | 0.170 |
Why?
|
Injury Severity Score | 3 | 2019 | 1014 | 0.170 |
Why?
|
Hawaii | 2 | 2023 | 105 | 0.170 |
Why?
|
Communications Media | 1 | 2019 | 43 | 0.170 |
Why?
|
Prions | 1 | 2021 | 180 | 0.170 |
Why?
|
Saline Solution, Hypertonic | 1 | 2019 | 110 | 0.170 |
Why?
|
Dementia | 3 | 2022 | 2518 | 0.170 |
Why?
|
Mannitol | 1 | 2019 | 181 | 0.170 |
Why?
|
Decision Support Techniques | 3 | 2014 | 1956 | 0.170 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 427 | 0.170 |
Why?
|
Massachusetts | 5 | 2020 | 8663 | 0.170 |
Why?
|
Antiemetics | 1 | 2020 | 177 | 0.160 |
Why?
|
Hand Strength | 2 | 2013 | 448 | 0.160 |
Why?
|
Odds Ratio | 6 | 2022 | 9849 | 0.160 |
Why?
|
Optic Nerve | 1 | 2022 | 554 | 0.160 |
Why?
|
Psychomotor Performance | 2 | 2021 | 1901 | 0.160 |
Why?
|
Texas | 1 | 2019 | 392 | 0.160 |
Why?
|
Emergency Medical Services | 2 | 2022 | 1917 | 0.160 |
Why?
|
Cohort Studies | 14 | 2023 | 40561 | 0.160 |
Why?
|
Acetaminophen | 1 | 2022 | 545 | 0.160 |
Why?
|
Schools | 4 | 2021 | 1433 | 0.160 |
Why?
|
Florida | 1 | 2019 | 435 | 0.160 |
Why?
|
Patient Selection | 1 | 2010 | 4215 | 0.160 |
Why?
|
Pilot Projects | 4 | 2021 | 8324 | 0.160 |
Why?
|
Early Diagnosis | 2 | 2020 | 1184 | 0.160 |
Why?
|
Carboxyhemoglobin | 1 | 2017 | 81 | 0.150 |
Why?
|
Hypotension, Orthostatic | 1 | 2021 | 255 | 0.150 |
Why?
|
Canada | 2 | 2022 | 2065 | 0.150 |
Why?
|
Neurofilament Proteins | 1 | 2019 | 318 | 0.150 |
Why?
|
Abortion, Induced | 1 | 2023 | 458 | 0.150 |
Why?
|
Recurrence | 3 | 2021 | 8340 | 0.150 |
Why?
|
Eye Movements | 1 | 2021 | 507 | 0.150 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2018 | 77 | 0.150 |
Why?
|
Age Distribution | 2 | 2013 | 2902 | 0.150 |
Why?
|
Nuclear Family | 1 | 2018 | 318 | 0.150 |
Why?
|
Vomiting | 1 | 2020 | 636 | 0.150 |
Why?
|
Problem Solving | 1 | 2020 | 440 | 0.150 |
Why?
|
Middle Aged | 19 | 2024 | 213383 | 0.150 |
Why?
|
Neurologic Examination | 2 | 2018 | 930 | 0.150 |
Why?
|
Visual Pathways | 1 | 2021 | 565 | 0.150 |
Why?
|
Carbon Dioxide | 1 | 2021 | 1150 | 0.140 |
Why?
|
Diffusion Tensor Imaging | 4 | 2022 | 2305 | 0.140 |
Why?
|
Models, Animal | 2 | 2023 | 2171 | 0.140 |
Why?
|
Social Justice | 1 | 2021 | 456 | 0.140 |
Why?
|
Headache | 5 | 2023 | 1226 | 0.140 |
Why?
|
Amphetamine | 1 | 2018 | 225 | 0.140 |
Why?
|
Rest | 2 | 2019 | 901 | 0.140 |
Why?
|
Aged | 16 | 2023 | 163280 | 0.140 |
Why?
|
Logistic Models | 6 | 2015 | 13408 | 0.140 |
Why?
|
Emergency Treatment | 1 | 2020 | 517 | 0.140 |
Why?
|
Tissue Culture Techniques | 1 | 2017 | 290 | 0.140 |
Why?
|
Interneurons | 1 | 2020 | 577 | 0.130 |
Why?
|
Health Services Accessibility | 2 | 2023 | 5137 | 0.130 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2021 | 721 | 0.130 |
Why?
|
Locomotion | 1 | 2018 | 378 | 0.130 |
Why?
|
Staining and Labeling | 1 | 2020 | 1100 | 0.130 |
Why?
|
Osteoarthritis | 1 | 2023 | 1036 | 0.130 |
Why?
|
Brain Injury, Chronic | 1 | 2015 | 68 | 0.130 |
Why?
|
State Government | 2 | 2020 | 372 | 0.130 |
Why?
|
Braces | 1 | 2015 | 135 | 0.130 |
Why?
|
Holoprosencephaly | 1 | 2014 | 22 | 0.130 |
Why?
|
Glutamic Acid | 1 | 2020 | 1169 | 0.130 |
Why?
|
Amnesia | 2 | 2014 | 248 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 8 | 2024 | 35421 | 0.120 |
Why?
|
Immobilization | 1 | 2015 | 236 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2015 | 588 | 0.120 |
Why?
|
International Classification of Diseases | 3 | 2016 | 867 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2020 | 1121 | 0.120 |
Why?
|
Carbon Monoxide | 1 | 2017 | 531 | 0.120 |
Why?
|
Microphthalmos | 1 | 2014 | 54 | 0.120 |
Why?
|
Medical History Taking | 1 | 2018 | 783 | 0.120 |
Why?
|
Erythropoietin | 2 | 2016 | 726 | 0.120 |
Why?
|
Truth Disclosure | 1 | 2018 | 436 | 0.120 |
Why?
|
Guideline Adherence | 2 | 2015 | 2266 | 0.120 |
Why?
|
Law Enforcement | 1 | 2015 | 109 | 0.120 |
Why?
|
Oncogene Proteins | 1 | 2018 | 749 | 0.120 |
Why?
|
Acute Kidney Injury | 1 | 2006 | 1972 | 0.120 |
Why?
|
Crime | 1 | 2015 | 215 | 0.120 |
Why?
|
Mullerian Ducts | 1 | 2014 | 198 | 0.120 |
Why?
|
Incidence | 5 | 2022 | 20947 | 0.120 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2016 | 3617 | 0.120 |
Why?
|
Paralysis | 1 | 2015 | 247 | 0.110 |
Why?
|
Hypothalamic Diseases | 1 | 2014 | 135 | 0.110 |
Why?
|
Louisiana | 1 | 2013 | 108 | 0.110 |
Why?
|
Boston | 6 | 2020 | 9313 | 0.110 |
Why?
|
Joint Diseases | 1 | 2017 | 480 | 0.110 |
Why?
|
Utah | 1 | 2013 | 126 | 0.110 |
Why?
|
Exploratory Behavior | 1 | 2014 | 270 | 0.110 |
Why?
|
Arnold-Chiari Malformation | 1 | 2015 | 154 | 0.110 |
Why?
|
Emergencies | 1 | 2019 | 1170 | 0.110 |
Why?
|
Migraine Disorders | 2 | 2023 | 1620 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2073 | 0.110 |
Why?
|
Hamartoma | 1 | 2014 | 238 | 0.110 |
Why?
|
Progestins | 1 | 2014 | 306 | 0.110 |
Why?
|
Visual Acuity | 1 | 2021 | 2530 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.100 |
Why?
|
Immunohistochemistry | 2 | 2020 | 11366 | 0.100 |
Why?
|
Physical Examination | 1 | 2018 | 1237 | 0.100 |
Why?
|
Hypercholesterolemia | 2 | 2020 | 1151 | 0.100 |
Why?
|
Exercise Test | 1 | 2019 | 2074 | 0.100 |
Why?
|
Learning | 1 | 2021 | 1713 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1164 | 0.100 |
Why?
|
Tauopathies | 1 | 2015 | 307 | 0.100 |
Why?
|
Employment | 2 | 2020 | 1132 | 0.100 |
Why?
|
Radius | 1 | 2014 | 422 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15076 | 0.100 |
Why?
|
Aging | 1 | 2010 | 8664 | 0.100 |
Why?
|
Sleep Deprivation | 1 | 2018 | 832 | 0.100 |
Why?
|
Heart Injuries | 1 | 2013 | 210 | 0.100 |
Why?
|
Life Style | 1 | 2023 | 3835 | 0.100 |
Why?
|
Disease Management | 2 | 2020 | 2459 | 0.100 |
Why?
|
Coma | 1 | 2015 | 475 | 0.100 |
Why?
|
Intracranial Hemorrhages | 2 | 2016 | 855 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2021 | 2731 | 0.100 |
Why?
|
Astrocytes | 2 | 2018 | 1270 | 0.100 |
Why?
|
Running | 2 | 2006 | 480 | 0.100 |
Why?
|
Hip Joint | 1 | 2017 | 1002 | 0.090 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2014 | 333 | 0.090 |
Why?
|
Chronic Disease | 2 | 2017 | 9146 | 0.090 |
Why?
|
Skull | 1 | 2015 | 813 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 722 | 0.090 |
Why?
|
Dopamine | 1 | 2018 | 1591 | 0.090 |
Why?
|
Thoracic Injuries | 1 | 2013 | 272 | 0.090 |
Why?
|
Space Perception | 2 | 2012 | 475 | 0.090 |
Why?
|
Retina | 1 | 2021 | 2616 | 0.090 |
Why?
|
Statistics, Nonparametric | 4 | 2019 | 2886 | 0.090 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2016 | 957 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2023 | 3297 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2022 | 1947 | 0.090 |
Why?
|
Prevalence | 5 | 2022 | 15226 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.090 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7279 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2751 | 0.090 |
Why?
|
Motor Skills | 1 | 2013 | 522 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2018 | 14557 | 0.090 |
Why?
|
Poverty | 1 | 2021 | 2660 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2020 | 3086 | 0.090 |
Why?
|
Empathy | 1 | 2014 | 474 | 0.090 |
Why?
|
Nanoparticles | 1 | 2021 | 1905 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9734 | 0.080 |
Why?
|
Body Water | 1 | 2010 | 343 | 0.080 |
Why?
|
Private Sector | 1 | 2012 | 392 | 0.080 |
Why?
|
Sex Factors | 4 | 2019 | 10397 | 0.080 |
Why?
|
Violence | 1 | 2015 | 909 | 0.080 |
Why?
|
Physicians, Women | 1 | 2015 | 486 | 0.080 |
Why?
|
Government Regulation | 1 | 2013 | 522 | 0.080 |
Why?
|
Fever | 1 | 2016 | 1616 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12959 | 0.080 |
Why?
|
Depressive Disorder | 1 | 2021 | 3748 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 547 | 0.080 |
Why?
|
Risk Assessment | 4 | 2018 | 23338 | 0.080 |
Why?
|
Stroke | 2 | 2021 | 9981 | 0.080 |
Why?
|
Geography | 1 | 2010 | 669 | 0.080 |
Why?
|
Sex Distribution | 1 | 2013 | 2297 | 0.080 |
Why?
|
Seizures | 1 | 2020 | 2859 | 0.080 |
Why?
|
Neuroglia | 1 | 2013 | 927 | 0.080 |
Why?
|
Neurons | 3 | 2018 | 9338 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2013 | 1438 | 0.080 |
Why?
|
Depression | 2 | 2024 | 7766 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2519 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13284 | 0.070 |
Why?
|
Registries | 2 | 2013 | 8089 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39050 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2010 | 981 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3327 | 0.070 |
Why?
|
Health Status | 2 | 2020 | 4034 | 0.070 |
Why?
|
Spinal Fractures | 1 | 2013 | 696 | 0.070 |
Why?
|
Sports Equipment | 2 | 2017 | 23 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3870 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3703 | 0.070 |
Why?
|
Appendicitis | 1 | 2012 | 645 | 0.070 |
Why?
|
Abdominal Pain | 1 | 2012 | 1063 | 0.070 |
Why?
|
Longitudinal Studies | 3 | 2021 | 13989 | 0.070 |
Why?
|
Decision Trees | 2 | 2019 | 506 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2020 | 63114 | 0.060 |
Why?
|
Heart Rate | 3 | 2021 | 4091 | 0.060 |
Why?
|
Medicaid | 2 | 2023 | 2736 | 0.060 |
Why?
|
Receptors, Erythropoietin | 2 | 2016 | 147 | 0.060 |
Why?
|
Anxiety | 2 | 2020 | 4297 | 0.060 |
Why?
|
Air Pollutants | 1 | 2017 | 2817 | 0.060 |
Why?
|
Arthritis | 1 | 2009 | 659 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5853 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.060 |
Why?
|
Sleep | 1 | 2018 | 4623 | 0.050 |
Why?
|
Hyponatremia | 1 | 2005 | 298 | 0.050 |
Why?
|
Cause of Death | 1 | 2012 | 3584 | 0.050 |
Why?
|
Emotions | 1 | 2014 | 2661 | 0.050 |
Why?
|
Paris | 1 | 2020 | 42 | 0.050 |
Why?
|
Ibuprofen | 1 | 2022 | 236 | 0.050 |
Why?
|
Blood-Brain Barrier | 2 | 2021 | 1017 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3229 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2016 | 1081 | 0.050 |
Why?
|
Retirement | 1 | 2022 | 215 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2013 | 3528 | 0.050 |
Why?
|
Washington | 1 | 2020 | 313 | 0.050 |
Why?
|
Quality Improvement | 1 | 2015 | 3749 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 295 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2016 | 57776 | 0.040 |
Why?
|
Microfilament Proteins | 2 | 2016 | 1152 | 0.040 |
Why?
|
Physical Exertion | 1 | 2022 | 695 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 449 | 0.040 |
Why?
|
Acute Disease | 2 | 2009 | 7149 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2016 | 2726 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3209 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7785 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15540 | 0.040 |
Why?
|
Parvalbumins | 1 | 2020 | 250 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 732 | 0.040 |
Why?
|
Gadolinium | 1 | 2024 | 952 | 0.040 |
Why?
|
Water | 1 | 2005 | 1395 | 0.040 |
Why?
|
North America | 1 | 2022 | 1249 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2024 | 859 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5255 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 170 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.040 |
Why?
|
Dizziness | 1 | 2021 | 251 | 0.040 |
Why?
|
Time | 1 | 2019 | 542 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2010 | 5097 | 0.040 |
Why?
|
Australia | 1 | 2020 | 1170 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15165 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 386 | 0.040 |
Why?
|
Saliva | 1 | 2021 | 809 | 0.040 |
Why?
|
Mobility Limitation | 1 | 2020 | 409 | 0.040 |
Why?
|
Maine | 1 | 2016 | 139 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2023 | 3778 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2019 | 2737 | 0.030 |
Why?
|
Epoetin Alfa | 1 | 2016 | 83 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9856 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2020 | 780 | 0.030 |
Why?
|
California | 1 | 2020 | 1402 | 0.030 |
Why?
|
Calpain | 1 | 2016 | 150 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1040 | 0.030 |
Why?
|
Nucleus Accumbens | 1 | 2018 | 366 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7729 | 0.030 |
Why?
|
Smoking | 2 | 2023 | 8987 | 0.030 |
Why?
|
Hospital Costs | 1 | 2021 | 985 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2019 | 6365 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1003 | 0.030 |
Why?
|
Weight Gain | 1 | 2005 | 2292 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2015 | 254 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2016 | 534 | 0.030 |
Why?
|
Goals | 1 | 2020 | 706 | 0.030 |
Why?
|
New England | 1 | 2017 | 1022 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1531 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10638 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2019 | 770 | 0.030 |
Why?
|
Reaction Time | 1 | 2021 | 2097 | 0.030 |
Why?
|
Oximetry | 1 | 2017 | 471 | 0.030 |
Why?
|
Movement Disorders | 1 | 2017 | 445 | 0.030 |
Why?
|
Speech Disorders | 1 | 2015 | 189 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 455 | 0.030 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 231 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.030 |
Why?
|
Arthralgia | 1 | 2017 | 456 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2018 | 1344 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2020 | 1578 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2015 | 570 | 0.030 |
Why?
|
Symporters | 1 | 2016 | 362 | 0.030 |
Why?
|
Ownership | 1 | 2015 | 332 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16365 | 0.030 |
Why?
|
Pennsylvania | 1 | 2013 | 613 | 0.030 |
Why?
|
Risk | 2 | 2015 | 9687 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2959 | 0.030 |
Why?
|
Ultrasonography | 2 | 2017 | 5985 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 933 | 0.030 |
Why?
|
Burnout, Professional | 1 | 2020 | 694 | 0.030 |
Why?
|
Leukoencephalopathies | 1 | 2014 | 238 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2021 | 3505 | 0.020 |
Why?
|
Income | 1 | 2020 | 1913 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2012 | 643 | 0.020 |
Why?
|
Demography | 1 | 2016 | 1656 | 0.020 |
Why?
|
Cytokines | 2 | 2016 | 7322 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2749 | 0.020 |
Why?
|
Patient Compliance | 1 | 2021 | 2684 | 0.020 |
Why?
|
Motivation | 1 | 2021 | 1971 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2214 | 0.020 |
Why?
|
Aggression | 1 | 2015 | 753 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3309 | 0.020 |
Why?
|
Electrocardiography | 1 | 2024 | 6442 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4037 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1425 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1622 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 603 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2013 | 441 | 0.020 |
Why?
|
Attention | 1 | 2020 | 2400 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3022 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1440 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5655 | 0.020 |
Why?
|
Mood Disorders | 1 | 2015 | 1106 | 0.020 |
Why?
|
Rats | 2 | 2016 | 24260 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2571 | 0.020 |
Why?
|
Blood Sedimentation | 1 | 2009 | 231 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3638 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3468 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1701 | 0.020 |
Why?
|
Brain Edema | 1 | 2012 | 617 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29144 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2017 | 1978 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3966 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.020 |
Why?
|
Body Mass Index | 1 | 2005 | 12720 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1706 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2216 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2440 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2015 | 1061 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5788 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3114 | 0.020 |
Why?
|
Memory Disorders | 1 | 2012 | 1184 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8554 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2009 | 1588 | 0.020 |
Why?
|
Arthritis, Infectious | 1 | 2009 | 367 | 0.020 |
Why?
|
Pneumonia | 1 | 2016 | 2133 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 4258 | 0.010 |
Why?
|
Drinking | 1 | 2005 | 197 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7880 | 0.010 |
Why?
|
Urine | 1 | 2005 | 370 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8301 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2017 | 4234 | 0.010 |
Why?
|
Lipids | 1 | 2014 | 3305 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 3658 | 0.010 |
Why?
|
Clinical Competence | 1 | 2017 | 4687 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2408 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 13033 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16689 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8480 | 0.010 |
Why?
|
Knee Joint | 1 | 2009 | 1680 | 0.010 |
Why?
|
Sodium | 1 | 2005 | 1623 | 0.010 |
Why?
|
Beverages | 1 | 2005 | 820 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12072 | 0.010 |
Why?
|
Neutrophils | 1 | 2009 | 3719 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2015 | 8037 | 0.010 |
Why?
|